Eeniella nana Cytochrome c oxidase subunit 2 (COX2) is a mitochondrial protein component of the electron transport chain in the yeast species Eeniella nana (also known as Brettanomyces nanus). This protein is encoded by the COX2 gene in the mitochondrial genome, which spans approximately 34.5 kbp in E. nana . The full-length protein consists of 247 amino acids and functions as part of the cytochrome c oxidase complex, which is crucial for cellular respiration. E. nana is phylogenetically related to the Dekkera/Brettanomyces yeasts, with its mtDNA sequence order identical to that of B. custersianus and B. naardenensis .
Recombinant E. nana COX2 is typically expressed in Escherichia coli expression systems. According to available research data, the full-length protein (amino acids 1-247) is commonly expressed with an N-terminal His-tag to facilitate purification . This expression system allows for scalable production of the protein for research purposes. While E. coli is the predominant expression system, the methodology resembles that used for other membrane proteins, which can include denaturation and renaturation steps to obtain functionally active protein, similar to the approaches used for human COX-2 .
For optimal stability and activity retention, recombinant E. nana COX2 should be stored at -20°C or -80°C upon receipt, with aliquoting necessary for multiple use to avoid repeated freeze-thaw cycles . When prepared for short-term use, working aliquots can be stored at 4°C for up to one week . The protein is typically supplied in a Tris/PBS-based buffer containing 6% trehalose at pH 8.0, which helps maintain protein stability during storage . Adding glycerol to a final concentration of 50% is recommended for long-term storage at -20°C/-80°C .
For optimal reconstitution of lyophilized recombinant E. nana COX2:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (50% is recommended as default)
Aliquot for long-term storage at -20°C/-80°C to prevent repeated freeze-thaw cycles
This methodology ensures protein stability while minimizing degradation. For membrane proteins like COX2, additional considerations may include the addition of mild detergents to maintain solubility, though specific detergent requirements for E. nana COX2 are not detailed in the available research.
The recombinant E. nana COX2 described in the research is produced with an N-terminal His-tag, suggesting that immobilized metal affinity chromatography (IMAC) is the primary purification method . Based on approaches used for similar proteins, a typical purification protocol would involve:
Cell lysis under denaturing conditions (potentially using urea or guanidine hydrochloride)
IMAC purification using Ni-NTA resin with appropriate imidazole gradient
Refolding through gradual dialysis to remove denaturants
Further purification using size-exclusion chromatography
For membrane proteins like COX2, purification strategies often involve denaturation followed by renaturation, as demonstrated in studies with truncated human COX-2 . This approach can yield protein with >90% purity as determined by SDS-PAGE .
Mitochondrial DNA mapping studies have provided significant insights into the evolutionary relationships between E. nana and other yeast species. Key findings include:
The sequence order for the 34.5 kbp mtDNA of E. nana is identical to that of B. custersianus (28.5 kbp) and B. naardenensis (41.7 kbp), suggesting close phylogenetic relationships
This sequence homology indicates that E. nana is affiliated with these two Brettanomyces species rather than with Dekkera species
In contrast, Dekkera species show different mitochondrial gene arrangements, with D. intermedia and D. bruxellensis having an inversion of the cytochrome b hybridizable region relative to the large ribosomal RNA (LrRNA) sequence
B. anomalus (57.7 kbp) exhibits an inversion of the cytochrome oxidase subunit 1 sequence with respect to the LrRNA sequence
These genomic arrangements provide valuable markers for yeast classification and evolutionary studies, indicating that E. nana represents a distinct evolutionary lineage within the Dekkera/Brettanomyces complex.
Researchers working with recombinant E. nana COX2 should anticipate several challenges typical of membrane proteins:
Expression efficiency: As a membrane protein, COX2 may form inclusion bodies when expressed in E. coli, requiring optimization of expression conditions including temperature, IPTG concentration, and induction time
Protein solubility: Maintaining the solubility of the protein during purification often requires careful selection of detergents or denaturant concentrations
Refolding efficiency: If purified under denaturing conditions, refolding to obtain functionally active protein may require extensive optimization
Activity assays: Developing reliable assays to confirm that the recombinant protein retains native functionality can be challenging
Similar challenges have been documented for human COX-2 expression in prokaryotic systems, where researchers have employed strategies such as truncating the protein to improve expression while retaining catalytic activity .
Validating the functional activity of recombinant E. nana COX2 requires assays that measure its role in the electron transport chain. Based on methodologies used for similar proteins, recommended approaches include:
Oxygen consumption assays: Measuring oxygen reduction rates in reconstituted systems
Spectroscopic methods: Monitoring changes in absorption spectra during electron transfer
Polarographic measurements: Using oxygen electrodes to detect activity
Reconstitution experiments: Incorporating the protein into liposomes or nanodiscs to restore native-like membrane environments
The protein's purity can be validated using SDS-PAGE analysis, which should show >90% purity for properly purified samples . Western blotting using anti-His antibodies can confirm the presence of the His-tagged protein.
Rigorous experimental design for studies involving recombinant E. nana COX2 should include:
Negative controls:
Empty vector-transformed E. coli processed in parallel
Heat-denatured recombinant COX2 to confirm activity loss
Inhibitor controls when performing activity assays
Positive controls:
Well-characterized COX2 from related species
Commercial standards where available
Validation controls:
Mass spectrometry analysis to confirm protein identity
Circular dichroism to assess secondary structure integrity
Size-exclusion chromatography to verify oligomeric state
These controls help distinguish specific effects from artifacts and ensure reproducibility of experimental findings.
Site-directed mutagenesis offers a powerful approach for investigating structure-function relationships in E. nana COX2. A systematic experimental strategy might include:
Identifying key residues: Analyze sequence alignments with well-characterized COX2 proteins to identify conserved amino acids likely to be functionally important
Designing mutations: Create point mutations that:
Alter metal-binding sites
Modify predicted transmembrane domains
Change potential interaction surfaces with other subunits
Expression and purification: Express and purify mutant proteins using the same methods as for wild-type
Functional characterization: Compare activity of mutants with wild-type using established assays
Structural analysis: Employ circular dichroism, thermal stability assays, or other techniques to detect structural changes resulting from mutations
This approach can help map functional domains and understand the molecular basis of COX2 activity in E. nana.
While the available research specifically mentions E. coli-based expression of E. nana COX2 , researchers should consider the advantages and limitations of different expression systems:
Each system offers distinct advantages that should be selected based on the specific research objectives, such as structural studies, functional characterization, or interaction analyses.
Research on E. nana COX2 provides valuable insights into mitochondrial function and evolution across yeast species. The identical sequence order of mtDNA in E. nana, B. custersianus, and B. naardenensis establishes important phylogenetic relationships , while the availability of recombinant protein enables detailed functional studies. Future research directions might include comparative analyses of respiratory efficiency across Dekkera/Brettanomyces species and investigation of COX2's role in adaptations to different environmental conditions.
Several emerging technologies could significantly advance our understanding of E. nana COX2:
Cryo-electron microscopy: For high-resolution structural determination without the need for crystallization
Nanodiscs and polymer-based membrane mimetics: To study the protein in more native-like membrane environments
Single-molecule FRET: To analyze conformational changes during function
Integrative structural biology approaches: Combining multiple experimental techniques with computational modeling
CRISPR-based genome editing: For in vivo studies of COX2 mutations in yeast models